IMPROVING PATIENT CARE- RESULTS FROM THE TEXAS NEWBORN SCREENING PERFORMANCE MEASURES PROJECT

Author(s)

Tiwana SK1, Tanksley S2, Williams D2, Douglas M21Health Partners, Bloomington, MN, USA, 2Texas Department of State Health Services, Austin, TX, USA

Advances in screening technology have led to rapid expansion of newborn screening as a public health initiative in the United States.  Due to variation across states in program implementation, there is a lack of standardization and accountability, which can affect quality of care.  Texas currently screens for 28 disorders. OBJECTIVES: The Texas Newborn Screening Performance Measures Project was initiated with the objective of developing evidence-based performance measures to improve quality, accountability and uniformity in the care. METHODS: A three step approach was used for identification and development of key measures for 7 most critical disorders: systematic reviews; impact assessment; and feasibility assessment.  Impact assessments (likert scale) were based on National Quality Measures Clearinghouse™ (NQMC) criteria: scientific soundness, relevance, health importance,  impact on quality of care, and ability to address disparities in care.   A likert scale was also used for feasibility assessment on key aspects: data availability, ease of collection, infrastructure and human resource needs, overall cost, and time constraints.  RESULTS: A total of 50 performance measures were supported by scientific evidence.  Impact and feasibility assessments led to the approval of 33/50 measures.  “Time to initiate treatment” received the highest scores on potential impact on patient outcomes (mean impact score 86.67/100, SD 1.5).  Other measures with potentially high impact (score >80/100) were: compliance with oral prophylactic medication and age at first Prevnar® vaccination in sickle cell disease; screening of at-risk family members in fatty acid disorders; frequency of growth assessments in congenital adrenal hyperplasia and phenylalanine levels in phenylketonuria.  “Time to treatment” for individual disorders was also ranked very high on feasibility (mean feasibility score 88.67/100, SD 3.88). CONCLUSIONS:   This is one of the first efforts to identify and develop evidence-based performance measures in newborn screening and can pave the way for system wide changes and development of national guidelines.   

Conference/Value in Health Info

2010-11, ISPOR Europe 2010, Prague, Czech Republic

Value in Health, Vol. 13, No. 7 (November 2010)

Code

PDB90

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Quality of Care Measurement

Disease

Diabetes/Endocrine/Metabolic Disorders, Pediatrics, Systemic Disorders/Conditions

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×